Study S002768

Investigation of Pharmacokinetic Properties of Single Subcutaneous Doses of NNC0174-0833 in Chinese Male Subjects Being Normal Weight, Overweight or With Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05254158
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 24
Start: 2022-03-03
Primary completion: 2022-09-07
Lead sponsor: Novo Nordisk A/S
Conditions: Overweight and Obesity
Interventions: DRUG:NNC0174 0833
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1247-7538

Registered primary outcomes

AUC0-∞, NNC0174-0833: The area under the NNC0174-0833 plasma concentration-time curve from time 0 to infinity after a single dose [From pre-dose (Day 1) to Visit 7 (Day 36)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.